| 多发性骨髓瘤的治疗进展 |
| |
| 引用本文： | 梁慧芬,罗放. 多发性骨髓瘤的治疗进展[J]. 现代诊断与治疗, 2007, 18(5): 291-294 |
| |
| 作者姓名： | 梁慧芬 罗放 |
| |
| 作者单位： | 解放军第181中心医院内分泌血液科,广西,桂林,541002 |
| |
| 摘 要： | 多发性骨髓瘤(MM)是一种起源于B细胞系并能够产生单克隆免疫球蛋白的恶性增生性疾病。我国骨髓瘤发病率为1/10万,约占恶性肿瘤的1%,发病年龄大都在50~60岁之间。MM尚无根治的方法。现对MM的联合治疗、干细胞移植、新型药物治疗及并发症的治疗进行论述。
|
| 关 键 词： | 多发性骨髓瘤 联合治疗 干细胞移植 新型药物治疗 并发症 |
| 文章编号： | 1001-8174（2007）05-0291-04 |
| 修稿时间： | 2007-07-31 |
Progress in Treatment of Multiple Myeloma |
| |
| LIANG Hui-fen,LUO Fang. Progress in Treatment of Multiple Myeloma[J]. Modern Diagnosis & Treatment, 2007, 18(5): 291-294 |
| |
| Authors: | LIANG Hui-fen LUO Fang |
| |
| Affiliation: | Department of Endocrinology and Hematology, the 181st Central Hospital of PLA, Guilin 541002, China |
| |
| Abstract: | Multiple myeloma(MM) is a kind of malignant hyperplastic diseases,which is origined from B cell line and can produce monoclonal immunoglobulin.The incidence of MM is a 100000th in China,which occupies one percent of malignant tumors.The morbidity age is mainly from 50 to 60 years old.The radical cure of MM is not found.The combined treatment of MM,stem cell transplatation,new type of pharmocotherapy and the treatment of complications are discussed. |
| |
| Keywords: | Multiple myeloma Combined treatment Stem cell transplatation New type of pharmocotherapy Complication |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
